Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary


Amneal Pharmaceuticals is owned by 45.12% institutional investors, 54.31% insiders, and 0.57% retail investors. Ubs group is the largest institutional shareholder, holding 7.11% of AMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.41% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals45.12%54.31%0.57%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustrySpecialty & Generic Drug Manufacturers Stocks32.91%9.51%57.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ubs group21.85M7.11%$138.74M
Vanguard group13.99M4.55%$88.86M
Tpg gp a12.33M4.01%$78.29M
Blackrock11.28M3.67%$71.64M
Rubric capital management lp10.72M3.49%$68.08M
Fosun4.66M1.51%$29.56M
Dimensional fund advisors lp4.28M1.39%$27.21M
Neuberger berman group3.57M1.16%$22.66M
Geode capital management3.41M1.11%$21.65M
State street3.39M1.10%$21.51M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fosun4.66M9.98%$29.56M
Tpg gp a12.33M1.79%$78.29M
Rubric capital management lp10.72M1.79%$68.08M
Tucker asset management1.11M1.54%$7.06M
Blackbarn capital partners lp2.00M1.13%$12.70M
Nantahala capital management2.67M0.99%$16.95M
Jackson creek investment advisors161.76K0.38%$1.03M
Hennessy advisors1.39M0.33%$8.82M
Signature wealth management partners66.67K0.32%$423.33K
Tranquilli financial advisor71.41K0.31%$458.48K

Top Buyers

HolderShares% AssetsChange
Ubs group21.85M0.03%21.67M
Blackrock11.28M0.00%2.12M
Hennessy advisors1.39M0.33%1.39M
Rubric capital management lp10.72M1.79%1.18M
Tucker asset management1.11M1.54%1.11M

Top Sellers

HolderShares% AssetsChange
Fosun4.66M9.98%-7.66M
Lsv asset management---1.06M
Teacher retirement system of texas27.11K0.00%-720.28K
Hillsdale investment management---699.72K
Susquehanna group, llp---666.75K

New Positions

HolderShares% AssetsChangeValue
Hennessy advisors1.39M0.33%1.39M$8.82M
Tucker asset management1.11M1.54%1.11M$7.06M
First trust advisors lp629.24K0.00%629.24K$4.00M
Segall bryant & hamill481.50K0.05%481.50K$3.06M
Jefferies financial group195.01K0.01%195.01K$1.24M

Sold Out

HolderChange
Wr wealth planners-59.00
Nelson, van denburg & campbell wealth management group-396.00
Meeder asset management-442.00
Concord wealth partners-600.00
Innealta capital-847.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241832.81%138,650,46928.21%451.20%1056.06%45-
Mar 31, 202417816.34%108,142,002-0.95%611.23%9916.47%452.27%
Dec 31, 20231536.25%109,174,2827.09%701.61%85-1.16%4437.50%
Sep 30, 202314412.50%101,946,0764.62%661.62%8648.28%32-11.11%
Jun 30, 2023128-12.33%97,441,2710.64%641.58%587.41%36-25.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.36M1.41%7.16K
iShares Russell 2000 ETF4.16M1.34%-9.35K
Vanguard Small Cap Index3.50M1.13%6.85K
Vanguard Small Cap Value Index Inv2.36M0.76%-822.00
Vanguard Institutional Extnd Mkt Idx Tr2.16M0.70%388.85K
Fidelity Small Cap Index1.62M0.52%-44.40K
Hennessy Cornerstone Growth Investor1.56M0.51%175.40K
CREF Stock R11.31M0.42%-
iShares Russell 2000 Growth ETF1.18M0.38%-
Columbia Small Cap Value II1.17M0.38%1.17M

Recent Insider Transactions


DateNameRoleActivityValue
Nov 15, 2024Daly Jason B. SVP, Chief Legal OfficerSell$375.89K
Aug 14, 2024BOYER ANDREW S Executive Vice PresidentSell$175.62K
Aug 15, 2024BOYER ANDREW S Executive Vice PresidentSell$315.77K
Aug 14, 2024Shah Nikita Executive Vice PresidentSell$775.00K
May 17, 2024Autor Deborah M.-Sell$157.73K

Insider Transactions Trends


DateBuySell
2024 Q3-3
2024 Q2-2
2024 Q1--
2023 Q4--
2023 Q3-1

AMRX Ownership FAQ


Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 45.12%, followed by 54.31% insiders and 0.57% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 32.91%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Ubs group (21.85M shares, 7.11%), Vanguard group (13.99M shares, 4.55%), and Tpg gp a (12.33M shares, 4.01%). Together, they hold 15.68% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Fosun is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.98% of its assets in 4.66M Amneal Pharmaceuticals shares, valued at 29.56M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amneal Pharmaceuticals shares, with 1.41% of its total shares outstanding invested in 4.36M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools